Connect with us

Technology

Chasing efficiency and digital maturity: CRB’s new Horizons report finds biopharma manufacturers going all-in on digitalization, continuous manufacturing and more

Published

on

Meeting patient demand for breakthrough drugs and therapies requires new efficiencies on the manufacturing floor, and the industry is responding

KANSAS CITY, Mo., Oct. 1, 2024 /PRNewswire/ — Biopharmaceutical manufacturers are spending big on automation and digitalization, as operational efficiency spearheads one of the most important investment cycles in the industry’s history. The trend, among the many strategies employed by manufacturers trying to do more with less in a volatile economic market, joins the storylines captured in CRB’s newest Horizons: Life Sciences report.

Available today as a free download, the report is built on the survey responses of 500 life sciences industry professionals and reflects the industry’s intense pursuit of digital innovation despite the budget headwinds facing capital and operational spending plans. Data found in the report confirms that widening adoption of sustainable and optimization technologies like automation, continuous manufacturing platforms and more resource-efficient systems will be critical as manufacturers meet the rising demand for blockbuster therapies and breakthrough pharmaceuticals, such as the GLP-1 class of weight loss drugs.

A telling data cut featured in the report brings this digitalization trend into focus: About 31 percent of respondents reported that digitalization and automation conversion projects represent their next capital focus, well above the next highest rated goal of major facility expansion.

“Given the broad cultural conversation around digitalization and its role in reshaping the manufacturing landscape, this result isn’t surprising,” Peter Walters, CRB Fellow, Advanced Therapies, and Jarrod Wrampe, CRB life sciences Project Director, write in their analysis of how digitalization is elbowing its way into capital spending discussions. “The need for these deeper digital integrations is so great that large, mid-sized and small companies have converged around it.”

CRB’s subject matter experts envisioned this year’s life sciences Horizons edition as a facility-focused report, with a table of contents arranged much like how today’s biopharma facilities are designed and built – taking a product from its R&D roots through to production and on to patients. In the report’s opening passages, CRB’s Vice President of Life Sciences Noel Maestre notes the resulting data and analysis “help lift the roof on the modern manufacturing facility and look inside.”

Among the report’s key findings:

In the laboratory environment, the integration of robotics and artificial intelligence (AI) is enhancing capacity, reliability and repeatability. With 80% of respondents having implemented or planning to implement AI within the next three years, the trend towards more computer-driven findings is unmistakable.Production processes are shifting rapidly toward continuous manufacturing, with three-quarters of respondents using, or planning for, continuous technologies within the next five years, signaling a significant change in manufacturing methodologies.Horizons data indicates a substantial shift towards continuous purification, with more than a fourfold growth anticipated over the next decade – reflecting broad understanding and adoption of its benefits.In drug product development, the concept of operator-free filling is gaining traction, with 91% of respondents viewing it as the future of the industry. Although this future may be years or decades away, equipment vendors and manufacturers are already moving in this direction, aiming for lights-out filling operations.Sustainability goals are driving the adoption of new technologies, with 87% of respondents operating with renewable electricity or planning to complete their transition by 2030.

About CRB

CRB is a leading provider of sustainable engineering, architecture, construction, and consulting solutions to the global life sciences and advanced technology industries. From 20 offices across the United States, Canada, and Europe, our professionals provide world-class solutions that drive success and positive change for our clients, our people, and our communities. CRB is a privately held company with a rich history of serving clients throughout the world, consistently striving for the highest standard of technical knowledge, creativity, and execution. Visit us at crbgroup.com, and follow us on LinkedIn.

MEDIA CONTACT INFORMATION:
Chris Clark: chris.clark@crbgroup.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/chasing-efficiency-and-digital-maturity-crbs-new-horizons-report-finds-biopharma-manufacturers-going-all-in-on-digitalization-continuous-manufacturing-and-more-302262956.html

SOURCE CRB Group Inc.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

CompTIA Spark introduces free high-quality technology curriculum for middle grade classrooms

Published

on

By

On World Teachers’ Day, the nonprofit organization highlights the importance of middle school teachers, empowers them to teach technology skills

DOWNERS GROVE, Ill., Oct. 5, 2024 /PRNewswire/ — Responding to a critical gap in technology education, CompTIA Spark has launched free technology curriculum specifically for middle grade classrooms, grades 5-8. It aims to support teachers so that they can teach the critical skills students need to succeed in whatever path they choose. The nonprofit organization worked with educators across the country to develop the curriculum.

“Getting this free resource into the hands of middle school teachers can help close the gap in technology education.”

“World Teachers’ Day celebrates how important teachers are,” says Randi Parker, chief of staff and vice president of CompTIA Spark. “And we know that middle school teachers in particular play such an important role in a student’s journey which is why they are the key to bringing technology education to more schools. We could not have developed this curriculum without them, and we can’t reach students without them.”

For about the past year, school districts as well as individual teachers have been implementing the CompTIA Spark curriculum in middle grade classrooms and providing feedback that allowed for a testing and development period prior to the full-scale launch. The schools that participated in this phase ranged from award-winning STEM schools to less-resourced ones, with all types of schools reporting the curriculum was a success and that students were engaged and excited to learn.

Getting students excited about technology and growing their confidence with hands-on learning is critical at the middle school level. Without access to quality technology education, students fall behind before they reach high school which means they do not have the digital fluency needed to succeed in school and in life. Filling this critical gap is the mission of CompTIA Spark.

With the new free curriculum, teachers can guide middle grade students through engaging project-based lessons that build capability using common applications and 21st century skills. Students gain a solid foundation in key technology concepts to prepare them for future opportunities — in high school and beyond.

Delivered through an online learning platform, the curriculum sparks interest in technology and how it is used in a wide variety of careers. For example, the Tech Exploration units have interactive lessons that show how tech skills are used in roles like product design, market research, accounting, marketing and more. Meanwhile, the Emerging Tech units focus on artificial intelligence (AI), cybersecurity, and smart home technology. Full access to the curriculum is available to middle grade educators absolutely free — to empower more teachers to teach the subject, even if they have not taught it previously.

A recent special report from Education Week highlighted how schools have been “struggling to recruit and retain math and science teachers for decades,” let alone educators who can teach technology subjects. The report also stressed the fact that current teachers need to be given opportunities to be able to teach new subjects related to emerging fields and technologies — with this being a solution to tackling the shortage.

“Because of the way the curriculum is intentionally designed, we are able to take the burden off the teacher by providing high-quality technology curriculum that middle grade teachers can use in their classroom regardless of their past experience with the subject,” says Parker. “Getting this free resource into the hands of teachers can help close the gap in technology education that currently exists at the middle school level. CompTIA Spark curriculum is free, and always will be free, because it is a gift from the tech industry to future generations.”

Districts, schools and individual teachers are invited to explore the curriculum and get started at comptiaspark.org.

About CompTIA Spark

CompTIA Spark develops free high-quality technology curriculum for middle grade classrooms to close a critical gap in technology education that exists before high school. This work improves student outcomes and success, and helps ensure a diverse talent pipeline for the technology workforce. CompTIA Spark is an independent 501(c)(3) nonprofit organization that operates as the charitable arm of the Computing Technology Industry Association (CompTIA), a leading voice and advocate for the global information technology ecosystem and a trusted provider of technical training and IT certifications. Learn more at comptiaspark.org.

MEDIA CONTACTS:
Laura Perillo and/or Cristina De Guia
news@comptiaspark.org

View original content to download multimedia:https://www.prnewswire.com/news-releases/comptia-spark-introduces-free-high-quality-technology-curriculum-for-middle-grade-classrooms-302268032.html

SOURCE CompTIA Spark

Continue Reading

Technology

SAUNEX Partners with Saudi SIIVC in Strategic EV Initiative

Published

on

By

The partnership will concentrate on the development and manufacturing of electric vehicles, enhancing industry capabilities

BANGKOK, Oct. 5, 2024 /PRNewswire/ — UNEX of the Netherlands, a global leader in the research and development of electric vehicles (EVs), and Siam Racing Automobiles (SRA) of Thailand, a world-class automotive design and engineering firm, have announced that their joint venture, SAUNEX, has entered into a strategic cooperation agreement with Saudi Arabia International Industrial Village (SIIVC). The alliance will establish a production facility for EVs in Saudi Arabia, aiming to extend their market reach across the Middle East, North Africa, and Southern Europe.

Chatchaval Jiaravanon, a member of the family that controls CP Group, addressed the audience at the signing ceremony. He highlighted the importance of automotive manufacturing as a benchmark of a nation’s industrial capabilities. Reflecting on CP Group’s past collaboration with China’s SAIC to set up a production facility for MG sports cars in Thailand, he noted that the success of automotive ventures relies critically on exemplary technology and leadership. The partnership between SAUNEX and SIIVC is aligned with Saudi Arabia’s Vision 2030 strategic initiative, emphasizing sustainable collaboration in the development, production, and marketing of EVs. The goal is to drive significant progress in Saudi Arabia’s EV sector and position SAUNEX as a beacon of successful international cooperation between Thailand and Saudi Arabia.

Mr. Jiaravanon also remarked that SAUNEX stands at the forefront of electric vehicle R&D, particularly in the application of battery swapping technology and the fields of automotive design and engineering. Their leading model, the Manto, is a luxury electric SUV that utilizes UNEX’s battery swapping technology, enhanced by SRA’s sophisticated design and engineering. It significantly outperforms competitors, offering a superior choice for future EVs free from the usual range limitations.

Top management executives from UNEX at the ceremony pointed out that under the leadership of Dr. Faisal Abdullah, CEO of SIIVC, the project aims to develop cutting-edge automotive production and battery swapping facilities in Saudi Arabia, manufacturing a full line-up of vehicle models including sedans, SUVs, and vans. The partnership also includes collaboration with CP Group and automotive supply chains in Thailand and China, aiming to create a sustainable and advanced industrial ecosystem that sets a global standard for the electric vehicle industry.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/saunex-partners-with-saudi-siivc-in-strategic-ev-initiative-302268179.html

SOURCE UNEX

Continue Reading

Technology

Israel Banned from UAE BioTech Symposium

Published

on

By

Israeli BioTech companies will not be permitted at the quarterly event with Roadshows throughout the Arab Gulf States, including the United Arab Emirates, Kuwait, Qatar, Oman, Bahrain and Saudi Arabia

In parallel, UAE BioTech Symposium has been dedicated to the memory of The Rockefeller University Nobel Laureate Professor Dr. Günter Blobel, MD. PhD., Founder of The Friends of Dresden.

ABU DHABI, UAE, Oct. 5, 2024 /PRNewswire/ — “The board of AmCham Abu Dhabi mandated that Chinese and Russian companies are not allowed. As Founding Chairman of AmCham Abu Dhabi BioTech Committee & Chairman of UAE BioTech Symposium, I mandate that Israeli companies are not allowed, says Dr. Kambiz Shekdar, PhD.

Dr. Shekdar is Owner and Chairman of the quarterly UAE BioTech Symposium launching Nove 2-6, 2024 in Abu Dhabi and Dubai, UAE. Registration for UAE BioTech Symposium is hosted at AmCham Abu Dhabi. The detailed program is available at https://www.uaebiotechsymposium.com.

“I spent 8 years in the lab with Günter as my mentor. He would often talk about how his family was packed in a car, passing through Dresden escaping Nazi Germany when the fire bombing happened. I remember each time he remembered how he could read the pages of the newspaper by the light of the fire kilometers away. He donated his prize money to all three religions because he understood that peace is the fundament for achieving our human potential,” add Shekdar.

“I saw the firebombing destruction of Dresden from very near,” Blobel told The Times of Israel upon Dr. Blobel’s passing on February 18, 2018, “only a few kilometers away; for an 8 1/2-year-old, this was all very impressive. The bombing was so bright that you could read the newspaper by the red sky.”

Complete information about UAE BioTech Symposium is available at the Chairman’s personal portal at this link: https://linktr.ee/kambizshekdar

About UAE BioTech Symposium Chairman Dr. Kambiz Shekdar, PhD
From invention at The Rockefeller University to IPO at New York Stock Exchange to scale-up drug discovery for jointly owned Made-in-Abu-Dhabi IP in the U.A.E., Dr. Kambiz Shekdar is the first U.S. Biotech Abu Dhabi Golden Visa Inventor transitioning to the U.A.E.

Dr. Shekdar, PhD invented Chromovert® Technology while he was a graduate doctoral student in the laboratory of his mentor, the late Nobel laureate & King Faisal Prize winner Dr. Günter Blobel, MD, PhD. at The Rockefeller University in New York City. For more than 20 years, Dr. Shekdar has been pursuing applications of the same platform technology, now including pursuing the creation of a joint venture with Emirati stakeholders to implement the by-now validated research engine as part of a national-level public-private partnership for drug discovery at scale in the U.A.E. Dr. Shekdar is also a member of the Abu Dhabi, UAE chapter of American Chambers of Commerce where he is Founding Chairman of the AmCham Abu Dhabi BioTech Committee.

https://www.linkedin.com/in/kambiz-shekdar-51a52a34/

About UAE BioTech Symposium
UAE BioTech Symposium in partnership with the AmCham Abu Dhabi BioTech Committee and Masdar City will host quarterly panel discussions and lab tours in Abu Dhabi, Dubai and roadshow destinations throughout the GCC and Middle East. The events are free with attendance limited to prioritize U.S. and international BioTech owners and executives. Program details will be posted online in Arabic and in English as registration for each event goes live via the AmCham Abu Dhabi website.

Arabic site for scientific program: http://www.uaebiotechsymposium.ae
English site for scientific program: https://www.uaebiotechsymposium.com

About AmCham BioTech Committee
The AmCham BioTech Committee was formed to establish a BioTech sector in Abu Dhabi with a focus on promoting opportunities for U.S. BioTech companies with a vision to be a thought leader and facilitator for U.S. corporate interests in the emerging BioTech sector in Abu Dhabi and throughout the Middle East. Since its founding, the BioTech committee has seen a notable uptick in interest from U.S.-based companies seeking to broaden their service offerings within the region. AmCham BioTech Committee founding members include Seconcell Bio, Intelligenix Advanced Diagnostics, Extend Biosciences, Halia Therapeutics and Jones Lang LaSalle Inc (JLL).
https://amchamabudhabi.org/biotech/

CONTACT: Kambiz Shekdar, +971585820175

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/israel-banned-from-uae-biotech-symposium-302268169.html

SOURCE Secondcell Bio, LLC; UAE BioTech Symposium

Continue Reading

Trending